PHILADELPHIA, Aug. 29 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (Nasdaq: ERES), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services, announced today that Dr. Michael J. McKelvey, the Company's President and Chief Executive Officer, and Richard Baron, the Company's Chief Financial Officer, will present at the Thomas Weisel Healthcare Conference at 3:15 p.m. Eastern on September 5, 2007 in the Phillips Room at The Four Seasons Hotel in Boston.
Interested parties may access a live audio webcast of the presentation by visiting the Company's corporate website at http://www.ert.com or at http://www.veracast.com/webcasts/twp/healthcare07/25113489.cfm. The webcast will be available via replay for 90 days.
About Thomas Weisel
Thomas Weisel Partners is an investment bank specializing in the growth sectors of the economy including the technology, healthcare and consumer sectors. Its value-added Investment Banking, Brokerage, and Equity Research groups focus on servicing U.S. and international emerging growth companies and institutional investors. Thomas Weisel Asset Management includes four private equity investment funds, growth portfolios and a distribution management service for private equity and venture capital funds. At a time when growth companies have become an underserved constituency on Wall Street, Thomas Weisel Partners remains a committed champion of growth. Its dedication to growth companies, combined with our extensive network of business relationships and proven execution capabilities, makes Thomas Weisel Partners a trusted advisor to our corporate clients and a valued resource to investors. Thomas Weisel Partners has built an entrepreneurial, performance-oriented culture. Its core values are based on high ethical standards, a strong client- first and team mindset and meritocracy in the workplace.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2007 financial guidance, involve a number of risks and uncertainties such as the company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Report on Form 10-K and 10Q filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Richard Baron Brett Maas
eResearchTechnology, Inc. Hayden Communications
|SOURCE eResearchTechnology, Inc.|
Copyright©2007 PR Newswire.
All rights reserved